本页面由Tiger Trade Technology Pte. Ltd.提供服务

ADMA Biologics Inc

10.31
+0.13001.28%
盘后:10.12-0.1900-1.84%19:57 EDT
成交量:376.50万
成交额:3,859.04万
市值:23.09亿
市盈率:14.72
高:10.36
开:10.19
低:10.03
收:10.18
52周最高:20.46
52周最低:7.21
股本:2.24亿
流通股本:2.11亿
量比:1.39
换手率:1.79%
股息:- -
股息率:- -
每股收益(TTM):0.7004
每股收益(LYR):0.6000
净资产收益率:41.90%
总资产收益率:21.78%
市净率:5.66
市盈率(LYR):17.18

数据加载中...

2022/07/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/06/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

重要事件披露

8-K - Current report
2022/06/21

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/25

重要事件披露

8-K - Current report
2022/03/24

重要事件披露

8-K - Current report
2022/03/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/09

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/03/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans